Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Seven Decades of Chemotherapy Clinical Trials: A Pan-Cancer Social Network Analysis

Xuanyi Li, Elizabeth A. Sigworth, Adrianne H. Wu, View ORCID ProfileJess Behrens, Shervin A. Etemad, View ORCID ProfileSeema Nagpal, View ORCID ProfileRonald S. Go, Kristin Wuichet, Eddy J. Chen, View ORCID ProfileSamuel M. Rubinstein, Neeta K. Venepalli, View ORCID ProfileBenjamin F. Tillman, View ORCID ProfileAndrew J. Cowan, View ORCID ProfileMartin W. Schoen, View ORCID ProfileAndrew Malty, View ORCID ProfileJohn P. Greer, Hermina D. Fernandes, Ari Seifter, View ORCID ProfileQingxia Chen, Rozina A. Chowdhery, Sanjay R. Mohan, View ORCID ProfileSummer B. Dewdney, View ORCID ProfileTravis Osterman, Edward P. Ambinder, View ORCID ProfileElizabeth I. Buchbinder, Candice Schwartz, View ORCID ProfileIvy Abraham, View ORCID ProfileMatthew J. Rioth, View ORCID ProfileNaina Singh, View ORCID ProfileSanjai Sharma, Michael Gibson, Peter C. Yang, View ORCID ProfileJeremy L. Warner
doi: https://doi.org/10.1101/19010603
Xuanyi Li
1Vanderbilt University
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth A. Sigworth
1Vanderbilt University
BA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Adrianne H. Wu
2Mount Holyoke College
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jess Behrens
1Vanderbilt University
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jess Behrens
Shervin A. Etemad
1Vanderbilt University
BS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seema Nagpal
3Stanford University
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Seema Nagpal
Ronald S. Go
4Mayo Clinic
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ronald S. Go
Kristin Wuichet
5Vanderbilt University Medical Center
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eddy J. Chen
6Massachusetts General Hospital, Harvard Medical School
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Samuel M. Rubinstein
5Vanderbilt University Medical Center
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Samuel M. Rubinstein
Neeta K. Venepalli
7University of Illinois at Chicago
MD, MBA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Benjamin F. Tillman
5Vanderbilt University Medical Center
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Benjamin F. Tillman
Andrew J. Cowan
8University of Washington
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew J. Cowan
Martin W. Schoen
9Saint Louis University
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martin W. Schoen
Andrew Malty
3Stanford University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrew Malty
John P. Greer
5Vanderbilt University Medical Center
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for John P. Greer
Hermina D. Fernandes
10University of North Dakota
MD, FACP
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ari Seifter
7University of Illinois at Chicago
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qingxia Chen
1Vanderbilt University
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Qingxia Chen
Rozina A. Chowdhery
7University of Illinois at Chicago
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sanjay R. Mohan
5Vanderbilt University Medical Center
MD, MSCI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Summer B. Dewdney
11Rush University
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Summer B. Dewdney
Travis Osterman
5Vanderbilt University Medical Center
DO, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Travis Osterman
Edward P. Ambinder
12Mount Sinai Medical Center
MD, FASCO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elizabeth I. Buchbinder
13Dana-Farber Cancer Institute, Harvard Medical School
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Elizabeth I. Buchbinder
Candice Schwartz
7University of Illinois at Chicago
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ivy Abraham
7University of Illinois at Chicago
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ivy Abraham
Matthew J. Rioth
14University of Colorado
MD, MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Matthew J. Rioth
Naina Singh
7University of Illinois at Chicago
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Naina Singh
Sanjai Sharma
15Sequoia Regional Cancer Center
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sanjai Sharma
Michael Gibson
5Vanderbilt University Medical Center
MD, PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter C. Yang
6Massachusetts General Hospital, Harvard Medical School
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeremy L. Warner
5Vanderbilt University Medical Center
MD, MS, FAMIA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jeremy L. Warner
  • For correspondence: jeremy.warner@vumc.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Clinical trials establish the standard of care for cancer and other diseases. While social network analysis has been applied to basic sciences, the social component of clinical trial research is not well characterized. We examined the social network of cancer clinical trialists and its dynamic development over more than 70 years, including the roles of subspecialization and gender in relation to traditional and network-based metrics of productivity.

Methods We conducted a social network analysis of authors publishing chemotherapy-based prospective trials from 1946-2018, based on the curated knowledge base HemOnc.org, examining: 1) network density; 2) modularity; 3) assortativity; 4) betweenness centrality; 5) PageRank; and 6) the proportion of co-authors sharing the same primary cancer subspecialty designation. Individual author impact and productive period were analyzed as a function of gender and subspecialty.

Findings From 1946-2018, the network grew to 29,197 authors and 697,084 co-authors. While 99.4% of authors were directly or indirectly connected as of 2018, the network had very few connections and was very siloed by cancer subspecialty. Small numbers of individuals were highly connected and had disproportionate impact (scale-free effects). Women were under-represented and likelier to have lower impact, shorter productive periods (P<0.001 for both comparisons), less centrality, and a greater proportion of co-authors in their same subspecialty. The past 30 years were characterized by a trend towards increased authorship by women, with new author parity anticipated in 2032. However, women remain a distinct minority of first/last authors, with parity not anticipated for 50+ years.

Interpretation The network of cancer clinical trialists is best characterized as a strategic or “mixed-motive” network, with cooperative and competitive elements influencing its appearance.

Network effects e.g., low centrality, which may limit access to high-profile individuals, likely contribute to ongoing disparities.

Funding Vanderbilt Initiative for Interdisciplinary Research; National Institutes of Health; National Science Foundation

Evidence before this study We reviewed the literature on social networks from the 1800’s to 2018. Additionally, MEDLINE was searched for (“Social Networking”[Mesh] OR “Social Network Analysis”) AND (“Clinical Trials as Topic”[Mesh] OR “Hematology”[Mesh] OR “Medical Oncology”[Mesh]) without date restriction. The MEDLINE search yielded 43 results, of which 8 were relevant; none considered gender nor temporality in their analyses. To our knowledge, there has not been any similar study of the dynamic social network of clinical trialists from the inception of the fields of medical oncology and hematology to the present.

Added value of this study This is the first dynamic social network analysis of cancer clinical trialists. We found that the network was sparse and siloed with a small number of authors having disproportionate impact and influence as measured by network metrics such as PageRank; these metrics have become more disproportionate over time. Women were under-represented and likelier to have lower impact, shorter productive periods, less network centrality, and a greater proportion of co-authors in their same cancer subspecialty.

Implications of all the available evidence While gender disparities have been demonstrated in many fields including hematology/oncology, our analysis is the first to show that network factors themselves are significantly implicated in gender disparity. The increasing coalescence of the network by traditional cancer type and around a small number of high-impact individuals implies challenges when the field pivots from traditionally disease-oriented subspecialties to a precision oncology paradigm. New mechanisms are needed to ensure diversity of clinical trialists.

Competing Interest Statement

We declare the following interests: P.C.Y. is Editor-in-Chief of HemOnc.org and co-founder of HemOnc.org LLC and owns stock of HemOnc.org LLC; J.L.W. is Deputy Editor of HemOnc.org and co-founder of HemOnc.org LLC and owns stock of HemOnc.org LLC; and S.N, R.S.G., E.J.C., S.M.R., N.K.V, B.F.T., A.J.C., M.W.S., H.D.F., A.S., R.A.C., S.R.M., S.B.D., T.J.O., E.I.B., C.S., I.A., M.J.R., N.S., S.S., and M.G. are members of the editorial board of HemOnc.org. All positions at HemOnc.org are voluntary and uncompensated, and the stock of HemOnc.org LLC has no monetary value; the authors declare that there are no financial conflicts of interest.

Funding Statement

This work was supported by the Vanderbilt Initiative for Interdisciplinary Research (J.B.); NIH grants P30 CA068485 (J.L.W.), T32 CA009515 (A.J.C.), T32 HG008341 (S.M.R.), U01 CA231840 (K.W. and J.L.W.), U24 CA194215 (E.A.S. and Q.C.); and NSF grant #1757644 (A.H.W.). None of the funders had any direct role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Disambiguated author names and names mapped to gender are available as supplemental files. Algorithms are available upon request.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted November 02, 2019.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Seven Decades of Chemotherapy Clinical Trials: A Pan-Cancer Social Network Analysis
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Seven Decades of Chemotherapy Clinical Trials: A Pan-Cancer Social Network Analysis
Xuanyi Li, Elizabeth A. Sigworth, Adrianne H. Wu, Jess Behrens, Shervin A. Etemad, Seema Nagpal, Ronald S. Go, Kristin Wuichet, Eddy J. Chen, Samuel M. Rubinstein, Neeta K. Venepalli, Benjamin F. Tillman, Andrew J. Cowan, Martin W. Schoen, Andrew Malty, John P. Greer, Hermina D. Fernandes, Ari Seifter, Qingxia Chen, Rozina A. Chowdhery, Sanjay R. Mohan, Summer B. Dewdney, Travis Osterman, Edward P. Ambinder, Elizabeth I. Buchbinder, Candice Schwartz, Ivy Abraham, Matthew J. Rioth, Naina Singh, Sanjai Sharma, Michael Gibson, Peter C. Yang, Jeremy L. Warner
medRxiv 19010603; doi: https://doi.org/10.1101/19010603
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Seven Decades of Chemotherapy Clinical Trials: A Pan-Cancer Social Network Analysis
Xuanyi Li, Elizabeth A. Sigworth, Adrianne H. Wu, Jess Behrens, Shervin A. Etemad, Seema Nagpal, Ronald S. Go, Kristin Wuichet, Eddy J. Chen, Samuel M. Rubinstein, Neeta K. Venepalli, Benjamin F. Tillman, Andrew J. Cowan, Martin W. Schoen, Andrew Malty, John P. Greer, Hermina D. Fernandes, Ari Seifter, Qingxia Chen, Rozina A. Chowdhery, Sanjay R. Mohan, Summer B. Dewdney, Travis Osterman, Edward P. Ambinder, Elizabeth I. Buchbinder, Candice Schwartz, Ivy Abraham, Matthew J. Rioth, Naina Singh, Sanjai Sharma, Michael Gibson, Peter C. Yang, Jeremy L. Warner
medRxiv 19010603; doi: https://doi.org/10.1101/19010603

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Oncology
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (556)
  • Anesthesia (135)
  • Cardiovascular Medicine (1766)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (313)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (661)
  • Epidemiology (10806)
  • Forensic Medicine (8)
  • Gastroenterology (593)
  • Genetic and Genomic Medicine (2958)
  • Geriatric Medicine (288)
  • Health Economics (534)
  • Health Informatics (1932)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (293)
  • HIV/AIDS (632)
  • Infectious Diseases (except HIV/AIDS) (12522)
  • Intensive Care and Critical Care Medicine (696)
  • Medical Education (300)
  • Medical Ethics (86)
  • Nephrology (324)
  • Neurology (2803)
  • Nursing (151)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1472)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (868)
  • Pharmacology and Therapeutics (366)
  • Primary Care Research (338)
  • Psychiatry and Clinical Psychology (2645)
  • Public and Global Health (5379)
  • Radiology and Imaging (1015)
  • Rehabilitation Medicine and Physical Therapy (597)
  • Respiratory Medicine (726)
  • Rheumatology (330)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (150)
  • Urology (126)